vs

Side-by-side financial comparison of Stran & Company, Inc. (SWAG) and X4 Pharmaceuticals, Inc (XFOR). Click either name above to swap in a different company.

Stran & Company, Inc. is the larger business by last-quarter revenue ($28.9M vs $28.8M, roughly 1.0× X4 Pharmaceuticals, Inc). X4 Pharmaceuticals, Inc runs the higher net margin — 1.0% vs 0.8%, a 0.1% gap on every dollar of revenue.

Stran & Company, Inc. provides branded promotional products, custom merchandise and integrated marketing solutions for corporate clients. It serves customers across retail, healthcare, technology, education and other sectors, supporting brand campaigns, customer engagement and employee incentive programs.

X4 Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel targeted therapies for rare immunological diseases and oncology indications with high unmet medical needs. It operates primarily across the U.S. and European markets, with a lead pipeline candidate for WHIM syndrome and multiple other preclinical and clinical assets for immune disorders and cancer.

SWAG vs XFOR — Head-to-Head

Bigger by revenue
SWAG
SWAG
1.0× larger
SWAG
$28.9M
$28.8M
XFOR
Higher net margin
XFOR
XFOR
0.1% more per $
XFOR
1.0%
0.8%
SWAG

Income Statement — Q4 FY2025 vs Q1 FY2025

Metric
SWAG
SWAG
XFOR
XFOR
Revenue
$28.9M
$28.8M
Net Profit
$243.0K
$282.0K
Gross Margin
30.4%
83.6%
Operating Margin
-0.1%
-32.8%
Net Margin
0.8%
1.0%
Revenue YoY
7.2%
Net Profit YoY
141.5%
100.5%
EPS (diluted)
$0.02
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SWAG
SWAG
XFOR
XFOR
Q4 25
$28.9M
Q3 25
$26.0M
Q2 25
$32.6M
Q1 25
$28.7M
$28.8M
Q4 24
$27.0M
Q3 24
$20.1M
Q2 24
$16.7M
Q1 24
$18.8M
$0
Net Profit
SWAG
SWAG
XFOR
XFOR
Q4 25
$243.0K
Q3 25
$-1.2M
Q2 25
$643.0K
Q1 25
$-393.0K
$282.0K
Q4 24
$-586.0K
Q3 24
$-2.0M
Q2 24
$-1.0M
Q1 24
$-491.0K
$-51.8M
Gross Margin
SWAG
SWAG
XFOR
XFOR
Q4 25
30.4%
Q3 25
27.2%
Q2 25
30.3%
Q1 25
29.6%
83.6%
Q4 24
32.5%
Q3 24
29.5%
Q2 24
32.8%
Q1 24
29.8%
Operating Margin
SWAG
SWAG
XFOR
XFOR
Q4 25
-0.1%
Q3 25
-6.9%
Q2 25
1.2%
Q1 25
-1.9%
-32.8%
Q4 24
-3.5%
Q3 24
-10.8%
Q2 24
-6.6%
Q1 24
-3.5%
Net Margin
SWAG
SWAG
XFOR
XFOR
Q4 25
0.8%
Q3 25
-4.8%
Q2 25
2.0%
Q1 25
-1.4%
1.0%
Q4 24
-2.2%
Q3 24
-10.1%
Q2 24
-6.1%
Q1 24
-2.6%
EPS (diluted)
SWAG
SWAG
XFOR
XFOR
Q4 25
$0.02
Q3 25
$-0.07
Q2 25
$0.03
Q1 25
$-0.02
$0.04
Q4 24
$-0.02
Q3 24
$-0.11
Q2 24
$-0.06
Q1 24
$-0.03
$-7.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SWAG
SWAG
XFOR
XFOR
Cash + ST InvestmentsLiquidity on hand
$11.6M
$40.3M
Total DebtLower is stronger
$75.0M
Stockholders' EquityBook value
$30.5M
$22.9M
Total Assets
$49.3M
$130.0M
Debt / EquityLower = less leverage
3.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SWAG
SWAG
XFOR
XFOR
Q4 25
$11.6M
Q3 25
$11.8M
Q2 25
$18.1M
Q1 25
$12.2M
$40.3M
Q4 24
$18.2M
Q3 24
$6.9M
Q2 24
$9.6M
Q1 24
$10.7M
$60.5M
Total Debt
SWAG
SWAG
XFOR
XFOR
Q4 25
Q3 25
Q2 25
Q1 25
$75.0M
Q4 24
Q3 24
Q2 24
Q1 24
$55.0M
Stockholders' Equity
SWAG
SWAG
XFOR
XFOR
Q4 25
$30.5M
Q3 25
$30.2M
Q2 25
$31.8M
Q1 25
$31.3M
$22.9M
Q4 24
$31.6M
Q3 24
$32.3M
Q2 24
$34.3M
Q1 24
$35.2M
$1.0M
Total Assets
SWAG
SWAG
XFOR
XFOR
Q4 25
$49.3M
Q3 25
$50.3M
Q2 25
$61.2M
Q1 25
$52.2M
$130.0M
Q4 24
$55.1M
Q3 24
$48.8M
Q2 24
$46.6M
Q1 24
$47.9M
$112.2M
Debt / Equity
SWAG
SWAG
XFOR
XFOR
Q4 25
Q3 25
Q2 25
Q1 25
3.27×
Q4 24
Q3 24
Q2 24
Q1 24
53.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SWAG
SWAG
XFOR
XFOR
Operating Cash FlowLast quarter
$161.0K
$-12.4M
Free Cash FlowOCF − Capex
$38.0K
FCF MarginFCF / Revenue
0.1%
Capex IntensityCapex / Revenue
0.4%
0.0%
Cash ConversionOCF / Net Profit
0.66×
-43.86×
TTM Free Cash FlowTrailing 4 quarters
$-5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SWAG
SWAG
XFOR
XFOR
Q4 25
$161.0K
Q3 25
$-5.4M
Q2 25
$6.4M
Q1 25
$-5.9M
$-12.4M
Q4 24
$1.3M
Q3 24
$-2.7M
Q2 24
$2.1M
Q1 24
$2.1M
$-33.6M
Free Cash Flow
SWAG
SWAG
XFOR
XFOR
Q4 25
$38.0K
Q3 25
$-5.9M
Q2 25
$6.3M
Q1 25
$-6.0M
Q4 24
$1.2M
Q3 24
$-2.9M
Q2 24
$1.9M
Q1 24
$1.9M
$-33.7M
FCF Margin
SWAG
SWAG
XFOR
XFOR
Q4 25
0.1%
Q3 25
-22.6%
Q2 25
19.5%
Q1 25
-21.0%
Q4 24
4.6%
Q3 24
-14.3%
Q2 24
11.6%
Q1 24
9.9%
Capex Intensity
SWAG
SWAG
XFOR
XFOR
Q4 25
0.4%
Q3 25
1.9%
Q2 25
0.2%
Q1 25
0.4%
0.0%
Q4 24
0.3%
Q3 24
0.7%
Q2 24
1.1%
Q1 24
1.0%
Cash Conversion
SWAG
SWAG
XFOR
XFOR
Q4 25
0.66×
Q3 25
Q2 25
9.99×
Q1 25
-43.86×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SWAG
SWAG

Promotional Products Dropshipping$11.2M39%
Casino Continuity Program$6.9M24%
Promotional Products Company Owned Inventory$4.6M16%
Promotional Products Bulk Dropshipping$3.8M13%
Promotional Products Thirdparty Distributor$1.8M6%
Other$610.0K2%

XFOR
XFOR

Segment breakdown not available.

Related Comparisons